The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...

Inspire Investing is pleased to announce that the Inspire Fidelis Multi-Factor ETF has been awarded a 5-star Overall ...

Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic ...

Resistance to venetoclax (Venclexta® and Venclyxto®, Abbvie / Genentech), the $2.5 billion blockbuster Chronic Lymphocytic Leukemia (CLL) therapy, is emerging as a ...

A planned Convention on the Prevention and Punishment of Crimes Against Humanity, which could be adopted as soon as 2029, has the potential to enhance protections for civilians at risk globally.

Emerging markets are undervalued, showing strong Q3 performance of 11.26%. Discover the promising outlook and key strategies ...

See related editorial at Key points Despite being preventable and curable, tuberculosis (TB) disease affects nearly 11 million people worldwide per year, more than 2000 of whom live in Canada.[1][2], ...